NCT01795404

Brief Summary

A cancer diagnosis is a stressful phenomenon and a life-threatening experience that creates immediate psychosocial distress for the patient and his or her family. Distress is also experienced across the disease trajectory. Stress can manifest in a variety of psychological symptoms, such as anxiety and depression, intrusive cancer-related thoughts, or physical symptoms, such as fatigue, increased pain, and impaired sleep. Intensified stress in cancer patients has been associated with increased morbidity and mortality, decreased immune function, increased relapse, and decreased health-related quality of life. Given the known negative impact of stress on cancer patients, stress has become a priority issue in cancer treatment and research. Targeting stress-related variables with psychosocial interventions has been an important emphasis in cancer-care models. One of these care modalities is Inquiry-based stress reduction. The IBSR intervention, developed by Byron Katie, is a simple yet powerful process of inquiry that teaches the individual to identify and question the thoughts that cause him or her to experience stress and suffering. It is a way to understand what is hurting the individual, and to address the cause of his or her problems with clarity. This mindful-process, named "The Work", facilitates that through four questions and a turnaround, which is a way of experiencing the opposite of what the individual believes in. The Work provides skills for self-inquiry and management of stressful thoughts which can be easily implemented in daily life. The study will focus on breast, colorectal and prostate cancer patients. These types of cancers have high incidence along with high survival rates. The primary objective is to examine the feasibility and effectiveness of IBSR for breast, colorectal and prostate cancer survivors on quality of life. We hypothesize that this intervention will lead to significant improvements in all quality of life domains (physical well-being, psychological well-being, social well-being etc.) Effects on secondary outcomes will be assessed, including depressive symptoms, anxiety and stress levels, and fear of recurrence. Physical symptoms (disturbance in sleeping patterns, fatigue, and pain), will be assessed as well. Biological measurements will be measured in blood samples in order to observe effects on neural and immune components. Additionally, we are interested in evaluating whether positive effects achieved from the IBSR program are modified by specific patient characteristics measured at baseline (optimism, social support, and spirituality).

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for phase_2 cancer

Timeline
Completed

Started Jun 2013

Typical duration for phase_2 cancer

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 17, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 20, 2013

Completed
3 months until next milestone

Study Start

First participant enrolled

June 1, 2013

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

February 20, 2013

Status Verified

February 1, 2013

Enrollment Period

3 years

First QC Date

February 17, 2013

Last Update Submit

February 17, 2013

Conditions

Keywords

IBSRCancer SurvivorsKatie ByronQuality of LifeStressStress reduction

Outcome Measures

Primary Outcomes (1)

  • Quality of Life (QoL)

    Validated 41 items questionnaire will be used to assess QoL, including: Measures of psychological status: Fear of recurrence, perceived stress, anxiety, and depressive symptoms. Physical symptoms: Fatigue, pain, sleep disturbance. Social concerns Spiritual well being

    All participants will be asked to fill the same questionnaires at the initiation of the study (T1) and again after 3 months (end of intervention)

Other Outcomes (1)

  • biological markers

    All participants will be asked to fill the same questionnaires at the initiation of the study (T1) and again after 3 months (end of intervention)

Study Arms (2)

Inquiry Based Stress Reduction (IBSR) Program

EXPERIMENTAL

During a 12-week intervention program, participants will be encouraged to identify and inquire their stressful thoughts. Through the use of self-inquiry practices participants are taught to increase awareness of their thoughts and feelings, to observe their emotional and physical responses during situations perceived by them as stressful, and allow their mind to return to its true, peaceful, creative nature. Through the process of self-inquiry, participants take an active role in investigating their stressful thoughts, and by this regulating their stress and managing symptoms and emotions, thus enabling them to cope better with the distress related to the possibility of cancer.

Behavioral: Inquiry Based Stress Reduction (IBSR)

Control group

NO INTERVENTION

Waited-list control

Interventions

Also known as: The Work meditation (Byron Katie)
Inquiry Based Stress Reduction (IBSR) Program

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants who were diagnosed with either:Breast cancer;Colorectal cancer;Prostate cancer.
  • years and older;
  • Awareness of their cancer diagnosis;
  • Within three months to eighteen months after the completion of surgery, chemotherapy, and/or radiotherapy.
  • Able to read and complete questionnaires on their own.

You may not qualify if:

  • Participants not speaking Hebrew;
  • Not able to give informed consent due to impaired mental or intellectual state
  • Advanced cancer stage
  • Current psychiatric diagnosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Nadir Arber, Prof.

    Tel Aviv Medical Center

    PRINCIPAL INVESTIGATOR
  • Shahar LevAri, PhD

    Tel Aviv Medical Center

    STUDY DIRECTOR

Central Study Contacts

Nadir Arber, Prof.

CONTACT

Shahar Lev- ari, PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 17, 2013

First Posted

February 20, 2013

Study Start

June 1, 2013

Primary Completion

June 1, 2016

Study Completion

December 1, 2016

Last Updated

February 20, 2013

Record last verified: 2013-02